Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.0Revenue (TTM) $M10.6Net Margin (%)-166.0Altman Z-Score-8.8
Enterprise Value $M7.1EPS (TTM) $-1.1Operating Margin %-151.1Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-165.8Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %-43.7Quick Ratio4.7Cash flow > EarningsN
Price/Sales1.45-y EBITDA Growth Rate %-52.4Current Ratio4.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-103.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-120.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)-215.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ROSG is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

    More From Other Websites
    Rosetta Genomics to Host 2016 Second Quarter Financial Results and Business Update Conference Call... Sep 20 2016
    Rosetta Genomics to Host 2016 Second Quarter Financial Results and Business Update Conference Call... Sep 20 2016
    Rosetta Genomics to Present at Upcoming September Conferences Sep 19 2016
    Data Validating the Utility of RosettaGX Reveal™ with Liquid-based Cytology Samples will be... Sep 14 2016
    RosettaGX Reveal™ Thyroid miRNA Classifier Now available to be Utilized on ThinPrep® Samples Sep 07 2016
    RosettaGX Reveal™ Thyroid miRNA Classifier Now Available to Be Utilized on ThinPrep® Samples Sep 07 2016
    Rosetta Genomics Selected by a Global Pharmaceutical Company to Supply FISH Testing Services for... Aug 24 2016
    Rosetta Genomics Selected by a Global Pharmaceutical Company to Supply FISH Testing Services for... Aug 24 2016
    Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of OncoGxSelect™ from Admera... Aug 04 2016
    Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of OncoGxSelect™ from Admera... Aug 04 2016
    Rosetta Expands Managed Care Coverage with New Preferred Provider Agreement with Galaxy Health... Aug 02 2016
    Rosetta Genomics Receives U.S. Patent Allowance for microRNA-based Ovarian Cancer Treatment Jul 11 2016
    Rosetta Genomics Gets Patent Allowance For microRNA-based Ovarian Cancer Treatment Jul 11 2016
    Rosetta Genomics Receives U.S. Patent Allowance for microRNA-based Ovarian Cancer Treatment Jul 11 2016
    Rosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference Jul 06 2016
    Rosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference Jul 06 2016
    Rosetta Expands Managed Care Coverage with New Preferred Provider Agreement for Entire Suite of... Jun 23 2016
    Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Jun 22 2016
    Rosetta Genomics Receives Approval from New York State for HEME FISH-based Assays Jun 21 2016
    Here’s Why These Five Stocks Are Gaining Ground on Tuesday Jun 21 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)